Oppenheimer & CO Inc Dexcom Inc Transaction History
Oppenheimer & CO Inc
- $6.52 Billion
- Q4 2024
A detailed history of Oppenheimer & CO Inc transactions in Dexcom Inc stock. As of the latest transaction made, Oppenheimer & CO Inc holds 20,251 shares of DXCM stock, worth $1.79 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
20,251
Previous 32,849
38.35%
Holding current value
$1.79 Million
Previous $2.2 Million
28.49%
% of portfolio
0.02%
Previous 0.03%
Shares
27 transactions
Others Institutions Holding DXCM
# of Institutions
1,085Shares Held
352MCall Options Held
8.45MPut Options Held
5.75M-
Vanguard Group Inc Valley Forge, PA46.5MShares$4.11 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$3.05 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.7MShares$1.47 Billion0.05% of portfolio
-
Baillie Gifford & CO14.6MShares$1.29 Billion0.9% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.4MShares$1.27 Billion0.24% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $34.1B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...